1. 119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated. (31st December 2020) Authors: Tica, Jelena; Guiñazú, Javier Ruiz; Andrews, Charles P; Davis, Matthew G; Essink, Brandon; Fogarty, Charles; Kerwin, Edward; Leroux-Roels, Isabel; Steenackers, Katie; Vandermeulen, Corinne; David, Marie-Pierre; Dezutter, Nancy; Fissette, Laurence; Koch, Juliane; Mesaros, Narcisa Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 121. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Immunogenic. (31st December 2020) Authors: Guiñazú, Javier Ruiz; Tica, Jelena; Andrews, Charles P; Davis, Matthew G; De Smedt, Philippe; Essink, Brandon; Fogarty, Charles; Kerwin, Edward; Leroux-Roels, Isabel; Vandermeulen, Corinne; David, Marie-Pierre; Dezutter, Nancy; De Schrevel, Nathalie; Fissette, Laurence; Mesaros, Narcisa Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 3. Phase 3 Pivotal Evaluation of 20-valent Pneumococcal Conjugate Vaccine (PCV20) Safety, Tolerability, and Immunologic Noninferiority in Participants 18 Years and Older. (31st December 2020) Authors: Essink, Brandon; Sabharwal, Charu; Xu, Xia; Sundaraiyer, Vani; Peng, Yahong; Moyer, Lisa; Pride, Michael W; Scully, Ingrid L; Jansen, Kathrin U; Gruber, William C; Scott, Daniel; Watson, Wendy Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized phase 1/2 study of the safety and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy adults 50 through 85 years of age. Issue 8 (3rd August 2021) Authors: Essink, Brandon; Peterson, James; Yacisin, Kari; Lal, Himal; Mirza, Sarah; Xu, Xia; Scully, Ingrid L.; Scott, Daniel A.; Gruber, William C.; Jansen, Kathrin U.; Watson, Wendy Journal: Human vaccines & immunotherapeutics Issue: Volume 17:Issue 8(2021) Page Start: 2691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antibody persistence and booster response following MenACWY-CRM vaccination in children as assessed by two different assay methods. Issue 32 (26th July 2019) Authors: Klein, Nicola P.; Block, Stan L.; Essink, Brandon; Barbi, Silvia; Smolenov, Igor; Keshavan, Pavitra Journal: Vaccine Issue: Volume 37:Issue 32(2019) Page Start: 4460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials. (20th September 2022) Authors: Siangphoe, Uma; Baden, Lindsey R; El Sahly, Hana M; Essink, Brandon; Ali, Kashif; Berman, Gary; Tomassini, Joanne E; Deng, Weiping; Pajon, Rolando; McPhee, Roderick; Dixit, Avika; Das, Rituparna; Miller, Jacqueline M; Zhou, Honghong Journal: Clinical infectious diseases Issue: Volume 76:Number 2(2023) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents – Results from a randomized, controlled, observer-blind phase II study. Issue 35 (23rd August 2018) Authors: Welsch, Jo Anne; Senders, Shelly; Essink, Brandon; Klein, Thomas; Smolenov, Igor; Pedotti, Paola; Barbi, Silvia; Verma, Bikash; Toneatto, Daniela Journal: Vaccine Issue: Volume 36:Issue 35(2018) Page Start: 5309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age. Issue 1 (January 2016) Authors: Johnston, William; Essink, Brandon; Kirstein, Judith; Forleo-Neto, Eduardo; Percell, Sandra; Han, Linda; Keshavan, Pavitra; Smolenov, Igor Journal: Pediatric infectious disease journal Issue: Volume 35:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial. (10th May 2022) Authors: El Sahly, Hana M; Baden, Lindsey R; Essink, Brandon; Montefiori, David; McDermont, Adrian; Rupp, Richard; Lewis, Michael; Swaminathan, Shobha; Griffin, Carl; Fragoso, Veronica; Miller, Vicki E; Girard, Bethany; Paila, Yamuna D; Deng, Weiping; Tomassini, Joanne E; Paris, Robert; Schödel, Florian; ... Journal: Journal of infectious diseases Issue: Volume 226:Number 10(2022) Page Start: 1731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults. Issue 2 (10th January 2020) Authors: Essink, Brandon; Fierro, Carlos; Rosen, Jeffrey; Figueroa, Amparo L.; Zhang, Bin; Verhoeven, Carole; Edelman, Jonathan; Smolenov, Igor Journal: Vaccine Issue: Volume 38:Issue 2(2020) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗